Consensus guideline
Heart toxicity from breast cancer radiotherapy: Current findings, assessment, and prevention
Piroth MD, Baumann R, Budach W, et al. · DEGRO Breast Cancer Expert Panel
DoseLab summary
Review by the DEGRO breast cancer expert panel, ending in recommended limits for the whole heart, the left ventricle and the LAD (Table 3). The authors state that the limits apply to left-sided breast radiotherapy, were developed mainly for whole-breast treatment, may be achievable with conventional and hypofractionated schedules, and may be unavoidably exceeded when the internal mammary nodes are treated. DoseLab read the values from the open-access full text.
Why this is useful
The German radiation oncology society's breast panel limits for the whole heart, left ventricle and LAD — the most widely quoted published LAD limits for breast planning.
Reference details
- Title
- Heart toxicity from breast cancer radiotherapy: Current findings, assessment, and prevention
- Authors / organization
- Piroth MD, Baumann R, Budach W, et al. · DEGRO Breast Cancer Expert Panel
- Publication / protocol
- Strahlenther Onkol. 2019;195(1):1–12 (online 11 October 2018)
- Version
- Pending verification
- Year
- 2019
- DOI
- 10.1007/s00066-018-1378-z
- Disease sites
- Breast
- Topics
- Breast, Heart, LAD, Dose Constraints, Cardiac substructures
- Fractionation context
- Conventional and hypofractionated (40–42.5 Gy at 2.5–2.67 Gy) whole-breast RT
- Last reviewed by DoseLab
- 2026-09-23